
-
Pro-Palestinian protest threat racks up tension for Italy's World Cup qualifier with Israel
-
Israel, Hamas agree to first phase of peace plan
-
How Donald Trump pulled off his Gaza deal
-
Trump calls for jailing of Illinois Democrats as troops arrive
-
Suspect in US court months after deadly Los Angeles fire
-
Trump says Israel, Hamas agree to first phase of peace plan
-
Boca Juniors manager Russo dies aged 69: Argentine Football Association
-
US faces travel delays as government shutdown wears on
-
Tigers rally to beat Mariners, stay alive in MLB playoffs
-
Breast cancer screening scandal outrages Spain
-
Man Utd win on women's Champions League debut, Chelsea held by Twente
-
Country music star clashes with Trump govt over immigration raids
-
Flintoff did not feel 'valued' by new Superchargers owners
-
Zidane's son Luca 'proud' to play for Algeria
-
'Daily struggle for survival' for Haiti children, UN report says
-
Kane out but Tuchel wants more of the same from England
-
US facing worsening flight delays as shutdown snarls airports
-
Outgoing French PM sees new premier named in next 48 hours
-
Ratcliffe gives Amorim three years to prove himself at Man Utd
-
Jane Goodall's final wish: blast Trump, Musk and Putin to space
-
Salah scores twice as Egypt qualify for 2026 World Cup
-
New 'Knives Out' spotlights Trump-era US political landscape
-
Failed assassin of Argentina's Kirchner given 10-year prison term
-
Man arrested over deadly January fire in Los Angeles
-
La Liga confirm 'historic' Barcelona match in Miami
-
France's Le Pen vows to block any government
-
Mooney ton rescues Australia in stunning World Cup win over Pakistan
-
Afghan mobile access to Facebook, Instagram intentionally restricted: watchdog
-
Medvedev to face De Minaur in Shanghai quarter-finals
-
Conceicao named as new coach of Al Ittihad
-
Victoria Beckham reveals struggle to reinvent herself in Netflix series
-
'Solids full of holes': Nobel-winning materials explained
-
Iran releases Franco-German accused of spying
-
Gisele Pelicot urges accused rapist to 'take responsibility'
-
BBVA, Sabadell clash heats up ahead of takeover deadline
-
World economy not doing as badly as feared, IMF chief says
-
Veggie 'burgers' face the chop as EU lawmakers back labeling ban
-
Former FBI chief James Comey pleads not guilty in case pushed by Trump
-
Germany raises growth forecasts, but warns reforms needed
-
Serie A chief blasts Rabiot's criticism of Milan match in Australia
-
From refugee to Nobel: Yaghi hails science's 'equalising force'
-
De Minaur, Auger-Aliassime through to Shanghai quarter-finals
-
Canal Istanbul stirs fear and uncertainty in nearby villages
-
Root backs England to end Ashes drought in Australia
-
British PM Starmer hails India opportunities after trade deal
-
England captain Kane could miss Wales friendly
-
Tennis increases support for players under corruption, doping investigation
-
Russia says momentum from Putin-Trump meeting 'gone'
-
EU wants key sectors to use made-in-Europe AI
-
De Minaur, Rinderknech through to Shanghai quarter-finals

US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
K.Sutter--VB